Mono-Linyah (ethinyl estradiol / norgestimate) Drug Interactions
A total of 401 drugs are known to interact with Mono-Linyah (ethinyl estradiol / norgestimate).
- 34 major drug interactions
- 322 moderate drug interactions
- 45 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Mono-Linyah (ethinyl estradiol / norgestimate) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- biotin
- bupropion
- clonazepam
- Flexeril (cyclobenzaprine)
- gabapentin
- hydroxyzine
- ibuprofen
- Imitrex (sumatriptan)
- Klonopin (clonazepam)
- lamotrigine
- metformin
- multivitamin
- omeprazole
- propranolol
- sertraline
- topiramate
- trazodone
- Zoloft (sertraline)
Mono-Linyah (ethinyl estradiol / norgestimate) alcohol/food interactions
There are 7 alcohol/food interactions with Mono-Linyah (ethinyl estradiol / norgestimate)
Mono-Linyah (ethinyl estradiol / norgestimate) disease interactions
There are 21 disease interactions with Mono-Linyah (ethinyl estradiol / norgestimate) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Mono-Linyah (ethinyl estradiol / norgestimate)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Pricing & Coupons
- En Español
- 54 Reviews
- Drug class: contraceptives
- FDA Alerts (1)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
